Ligand Pharmaceuticals | LGND - 股本和储备



金融业
股票价格
USD
资产
USD 1.56B
现金及等价物
USD 174.93M
销售成本
USD 11.9M
流动资产
USD 832.27M
流动负债
USD 37.45M
债务
USD 451M
EBIT
USD 158.89M
EBITDA
USD 150.32M
员工
68
EPS每股收益
USD 2.02
股本和储备
USD 1.02B
销售毛利
USD 155.28M
债务利息支出
USD 910K
利息收入
USD 3.87M
贷款资金
USD 445.49M
市值
USD 3.55B
净收入
USD 117.27M
营业费用
USD 8.29M
营业利润
USD 158.89M
普通股股本
USD 19.66M
PE价格收益
60.65
税前利润
USD 141.14M
销售收入
USD 59.66M
销售和管理费用
USD 28.45M
股票
USD 9.13M
贸易债权人
USD 3.24M
应收帐款人
USD 58.1M


股本和储备 更改 日
Agenus USD -271.11M 3.03M 2025-12
Amgen USD 8.66B 961M 2025-12
Anika Therapeutics USD 143.46M 3.34M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Enviri Corporation USD 255.06M 106.02M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Merck USD 51.85B 2.79B 2025-09
Pacira USD 693.11M 34.1M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Veracyte USD 1.26B 36.61M 2025-09